Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: J Pediatr. 2008 Oct 31;154(3):379–384.e2. doi: 10.1016/j.jpeds.2008.09.021

Table 5.

Patients Treated with Additional PH Medications After Initiation of Sildenafil

Patient Medication(s) Added Reason for Medication Days After Sildenafil Initiation Days of Medication Use Remained on drug at latest follow-up
1 Bosentan Sildenafil intolerance 950 155 Yes
2 CCB Lack of echocardiogram improvement 75 269 Yes
3 Epoprostenol Lack of echocardiogram improvement 18 10 No
4 CCB Systemic hypertension 66 66 Yes
5 Bosentan Lack of echocardiogram improvement 108 490 No
6 Bosentan Lack of echocardiogram improvement 129 112 Yes
7 Epoprostenol Lack of echocardiogram improvement 16 28 No
Bosentan Lack of echocardiogram improvement 56 191 Yes

PH = pulmonary hypertension; CCB = calcium channel blocker